Interplay of chloride levels and palladium( ii )-catalyzed O -deallenylation bioorthogonal uncaging reactions

as the predominant active species. These insights provide the basis for the design of π-allylpalladium catalysts suited for selective uncaging within specific cellular environments, potentially enhancing targeted therapeutic applications.